October 2016

CNS10-NPC-GDNF for the Treatment of ALS

Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Biological: Stem cell (HPC) implantation
Sponsor:   Cedars-Sinai Medical Center
Not yet recruiting - verified October 2016

New Insights into Amyotrophic Lateral Sclerosis (ALS)

‘RNA based therapy as a treatment for amyotrophic lateral sclerosis (ALS)’ ALS ... Paul Taylor, Howard Hughes Medical Institute and St. Jude Children's Research Hospital; John P. Donohue, Manuel Ares Jr., UC Santa Cruz; and Steven Finkbeiner, Gladstone ...

ALS study reveals role of RNA-binding proteins

Although only 10 percent of amyotrophic lateral sclerosis cases are hereditary ... is an independent federal agency that supports fundamental research and education across all fields of science and engineering. In fiscal year (FY) 2016, its budget is ...